EdgarLookup

CAMDEN NATIONAL CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CAMDEN NATIONAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
156.1%
Profit Margin
Net income ÷ revenue
0.9%
Return on Assets
Net income ÷ assets
9.01x
Debt-to-Equity
Total liabilities ÷ equity
+17%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $41.74M Mar 6, 2026
FY2025 Dec 31, 2024 $35.69M Mar 6, 2026
FY2025 Dec 31, 2023 $33.57M Mar 6, 2026
FY2024 Dec 31, 2022 $33.27M Mar 7, 2025
FY2023 Dec 31, 2021 $31.95M Mar 8, 2024
FY2022 Dec 31, 2020 $27.74M Mar 10, 2023
FY2021 Dec 31, 2019 $28.33M Mar 11, 2022
FY2020 Dec 31, 2018 $26.82M Mar 15, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $65.16M Mar 6, 2026
FY2025 Dec 31, 2024 $53.00M Mar 6, 2026
FY2025 Dec 31, 2023 $43.38M Mar 6, 2026
FY2024 Dec 31, 2022 $61.44M Mar 7, 2025
FY2023 Dec 31, 2021 $69.01M Mar 8, 2024
FY2020 Dec 31, 2020 $18.28M Mar 15, 2021
FY2020 Sep 30, 2020 $16.78M Mar 15, 2021
FY2020 Jun 30, 2020 $10.94M Mar 15, 2021
FY2020 Mar 31, 2020 $13.49M Mar 15, 2021
FY2020 Dec 31, 2019 $15.24M Mar 15, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $63.91M Mar 6, 2026
FY2025 Dec 31, 2024 $60.93M Mar 6, 2026
FY2025 Dec 31, 2023 $67.51M Mar 6, 2026
FY2024 Dec 31, 2022 $105.18M Mar 7, 2025
FY2023 Dec 31, 2021 $142.72M Mar 8, 2024
FY2022 Dec 31, 2020 $18.23M Mar 10, 2023
FY2021 Dec 31, 2019 $32.87M Mar 11, 2022
FY2020 Dec 31, 2018 $64.33M Mar 15, 2021
FY2019 Dec 31, 2017 $58.33M Mar 11, 2020
FY2018 Dec 31, 2016 $57.42M Mar 13, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.71M Mar 6, 2026
FY2025 Dec 31, 2024 $5.58M Mar 6, 2026
FY2025 Dec 31, 2023 $2.62M Mar 6, 2026
FY2024 Dec 31, 2022 $2.18M Mar 7, 2025
FY2023 Dec 31, 2021 $1.85M Mar 8, 2024
FY2022 Dec 31, 2020 $2.93M Mar 10, 2023
FY2021 Dec 31, 2019 $4.27M Mar 11, 2022
FY2020 Dec 31, 2018 $5.02M Mar 15, 2021
FY2019 Dec 31, 2017 $2.84M Mar 11, 2020
FY2018 Dec 31, 2016 $1.67M Mar 13, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.97B Mar 6, 2026
FY2025 Dec 31, 2024 $5.81B Mar 6, 2026
FY2024 Dec 31, 2023 $5.71B Mar 7, 2025
FY2023 Dec 31, 2022 $5.67B Mar 8, 2024
FY2022 Dec 31, 2021 $5.50B Mar 10, 2023
FY2021 Dec 31, 2020 $4.90B Mar 11, 2022
FY2020 Dec 31, 2019 $4.43B Mar 15, 2021
FY2019 Dec 31, 2018 $4.30B Mar 11, 2020
FY2018 Dec 31, 2017 $4.07B Mar 13, 2019
FY2017 Dec 31, 2016 $3.86B Mar 9, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.28B Mar 6, 2026
FY2025 Dec 31, 2024 $5.27B Mar 6, 2026
FY2024 Dec 31, 2023 $5.22B Mar 7, 2025
FY2023 Dec 31, 2022 $5.22B Mar 8, 2024
FY2022 Dec 31, 2021 $4.96B Mar 10, 2023
FY2021 Dec 31, 2020 $4.37B Mar 11, 2022
FY2020 Dec 31, 2019 $3.96B Mar 15, 2021
FY2019 Dec 31, 2018 $3.86B Mar 11, 2020
FY2018 Dec 31, 2017 $3.66B Mar 13, 2019
FY2017 Dec 31, 2016 $3.47B Mar 9, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $696.56M Mar 6, 2026
FY2025 Dec 31, 2024 $531.23M Mar 6, 2026
FY2025 Dec 31, 2023 $495.06M Mar 6, 2026
FY2025 Dec 31, 2022 $451.28M Mar 6, 2026
FY2024 Dec 31, 2021 $541.29M Mar 7, 2025
FY2023 Dec 31, 2020 $529.31M Mar 8, 2024
FY2022 Dec 31, 2019 $473.42M Mar 10, 2023
FY2021 Dec 31, 2018 $435.83M Mar 11, 2022
FY2020 Dec 31, 2017 $403.41M Mar 15, 2021
FY2019 Dec 31, 2016 $391.55M Mar 11, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $151.51M Mar 6, 2026
FY2025 Dec 31, 2024 $94.70M Mar 6, 2026
FY2024 Dec 31, 2023 $94.70M Mar 7, 2025
FY2023 Dec 31, 2022 $94.70M Mar 8, 2024
FY2022 Dec 31, 2021 $94.70M Mar 10, 2023
FY2021 Dec 31, 2020 $94.70M Mar 11, 2022
FY2020 Dec 31, 2019 $94.70M Mar 15, 2021
FY2019 Dec 31, 2018 $94.70M Mar 11, 2020
FY2018 Dec 31, 2017 $94.70M Mar 13, 2019
FY2017 Dec 31, 2016 $94.70M Mar 9, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $545.15M Mar 6, 2026
FY2025 Dec 31, 2024 $509.45M Mar 6, 2026
FY2024 Dec 31, 2023 $481.01M Mar 7, 2025
FY2023 Dec 31, 2022 $462.16M Mar 8, 2024
FY2022 Dec 31, 2021 $424.41M Mar 10, 2023
FY2021 Dec 31, 2020 $377.50M Mar 11, 2022
FY2020 Dec 31, 2019 $340.58M Mar 15, 2021
FY2019 Dec 31, 2018 $302.03M Mar 11, 2020
FY2018 Dec 31, 2017 $266.72M Mar 13, 2019
FY2017 Dec 31, 2016 $249.42M Mar 9, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $67.00M Mar 13, 2019
FY2018 Dec 31, 2017 $102.97M Mar 13, 2019
FY2018 Dec 31, 2016 $87.71M Mar 13, 2019
FY2018 Dec 31, 2015 $79.49M Mar 13, 2019
FY2017 Dec 31, 2014 $60.81M Mar 9, 2018
FY2016 Dec 31, 2013 $51.36M Mar 7, 2017
FY2015 Dec 31, 2012 $58.29M Mar 11, 2016
FY2014 Dec 31, 2011 $39.33M Mar 10, 2015
FY2013 Dec 31, 2010 $31.01M Mar 12, 2014
FY2012 Dec 31, 2009 $29.77M Feb 28, 2013

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2016 Dec 31, 2016 $10.79M Mar 7, 2017
FY2016 Dec 31, 2015 $35.91M Mar 7, 2017
FY2015 Dec 31, 2014 $31.02M Mar 11, 2016
FY2014 Dec 31, 2013 $31.13M Mar 10, 2015
FY2013 Dec 31, 2012 $67.26M Mar 12, 2014
FY2012 Dec 31, 2011 $72.73M Feb 28, 2013

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Mar 6, 2026
FY2025 Dec 31, 2024 3 Mar 6, 2026
FY2025 Dec 31, 2023 2 Mar 6, 2026
FY2024 Dec 31, 2022 4 Mar 7, 2025
FY2023 Dec 31, 2021 4 Mar 8, 2024
FY2020 Dec 31, 2020 1 Mar 15, 2021
FY2020 Sep 30, 2020 1 Mar 15, 2021
FY2020 Jun 30, 2020 0 Mar 15, 2021
FY2020 Mar 31, 2020 0 Mar 15, 2021
FY2020 Dec 31, 2019 1 Mar 15, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Mar 6, 2026
FY2025 Dec 31, 2024 3 Mar 6, 2026
FY2025 Dec 31, 2023 2 Mar 6, 2026
FY2024 Dec 31, 2022 4 Mar 7, 2025
FY2023 Dec 31, 2021 4 Mar 8, 2024
FY2020 Dec 31, 2020 1 Mar 15, 2021
FY2020 Sep 30, 2020 1 Mar 15, 2021
FY2020 Jun 30, 2020 0 Mar 15, 2021
FY2020 Mar 31, 2020 0 Mar 15, 2021
FY2020 Dec 31, 2019 0 Mar 15, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 16.92M Mar 6, 2026
FY2025 Dec 31, 2024 14.58M Mar 6, 2026
FY2024 Dec 31, 2023 14.57M Mar 7, 2025
FY2023 Dec 31, 2022 14.57M Mar 8, 2024
FY2022 Dec 31, 2021 14.74M Mar 10, 2023
FY2021 Dec 31, 2020 14.91M Mar 11, 2022
FY2020 Dec 31, 2019 15.14M Mar 15, 2021
FY2019 Dec 31, 2018 15.59M Mar 11, 2020
FY2018 Dec 31, 2017 15.52M Mar 13, 2019
FY2017 Dec 31, 2016 15.48M Mar 9, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $28.47M Mar 6, 2026
FY2025 Dec 31, 2024 $24.56M Mar 6, 2026
FY2025 Dec 31, 2023 $24.54M Mar 6, 2026
FY2024 Dec 31, 2022 $23.51M Mar 7, 2025
FY2023 Dec 31, 2021 $21.08M Mar 8, 2024
FY2022 Dec 31, 2020 $19.84M Mar 10, 2023
FY2021 Dec 31, 2019 $18.57M Mar 11, 2022
FY2020 Dec 31, 2018 $17.17M Mar 15, 2021
FY2019 Dec 31, 2017 $14.32M Mar 11, 2020
FY2018 Dec 31, 2016 $12.39M Mar 13, 2019